IL13RA1 and central nervous system cancer: The affinity of IL-13 to IL-13RA2 was found to be stronger than that to IL-13RA1, which inhibits the IL-13RA1/IL-4R signaling pathway (134), suggesting IL-13RA2 as a powerful target for anti-glioma therapy (135).